Moderna, Inc.

Healthcare · EUR · XETRA

0QFT212

Price

€39.76

-3.90%

Cap

€15.94B

Earnings

—

30d Trend

-2.4%

0QF

Loading chart data...

0 days · % change from startPowered by Brain47

VolatilityHigh

80% annualised over 90 days

BRAIN47 SIGNAL

MODERATE

Risk Level80

Quality32

Momentum80

Technical60

Fundamentals35

Raw weighted: 51×Macro 0.99 (−1%)=50

RISK

80/100

90d Volatility

80.2%High

ATR %

5.4%High daily moves

Max Drawdown (1Y)

-31.4%Volatile

QUALITY

32/100

ROE (avg)

-36.6%Negative

Piotroski F-Score

4/9Average

Margin Stability

CV 31.8%Volatile

Accruals

-7.7%Cash earnings

MOMENTUM

80/100

12-1M Momentum

+65.6%Strong uptrend

6-1M Momentum

+78.7%Positive

1M Return

+2.0%Stable

Relative Strength

-0.5% vs sectorIn-line

TECHNICAL

60/100

RSI (14)

41.3Neutral

Price vs SMA200

+24.5%Bullish trend

MACD

-0.16Bearish momentum

Bollinger Band

25%Mid-range

SMA Cross

Death CrossDeath Cross

Trend Quality (KER)

0.037Noisy/choppy

FUNDAMENTALS

35/100

P/S

7.2Fair

Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 100%

Running historical backtest...

BRAIN47 HORIZON ANALYSIS

<3 months44

3-12 months ★65

1-5+ years39

6-9 month opportunity — emerging trend

BRAIN47'S ASSESSMENT

I rate Moderna, Inc. at 50/100 — a MODERATE reading on the Brain47 Signal. The strongest factor is momentum at 80/100. I classify this as a growth position with the strongest thesis on a medium-term horizon.

PAST PERFORMANCE

1 MONTH

+2.0%

3 MONTHS

-8.9%

12 MONTHS

+67.7%

Trailing returns — past performance, not a projection.

DETAILED ANALYSIS

6-9 month opportunity — emerging trend. Momentum (80) and Technical (60) are the primary strengths. I note an elevated risk profile — this warrants closer monitoring. Historical volatility is elevated at 80%. I classify this as a growth position — strong momentum combined with growth potential points to capital appreciation.

growthScore: 50/100

Want full analysis on every stock?

Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.

Join Brain47 — Free

Generated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.